Company Valuation: Laboratorio Farmaceutico Erfo S.p.A.

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025
Market Cap 1 18.27 11.79 10.8 12.53
Change - -35.47% -8.4% 16.03%
Enterprise Value (EV) 1 17.38 11.41 10.81 12.83
Change - -34.34% -5.31% 18.7%
P/E 25.5x 19.1x 30.8x 17x
PBR 2.33x 1.43x 1.44x 1.57x
PEG -0.3x -1.4x -0.8x 0x
Capitalization / Revenue 3.87x 1.99x 1.79x 1.29x
EV / Revenue 3.68x 1.92x 1.79x 1.32x
EV / EBITDA 11.8x 8.02x 10.1x 7x
EV / EBIT 17.6x 13.6x 20.6x 12x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - 0.06 - -
Rate of return - 4.58% - -
EPS 2 0.0796 0.0686 0.0411 0.0865
Distribution rate - 87.4% - -
Net sales 1 4.719 5.932 6.032 9.732
EBITDA 1 1.474 1.423 1.065 1.832
EBIT 1 0.987 0.8367 0.5239 1.066
Net income 1 0.7161 0.5903 0.3528 0.737
Net Debt 1 -0.8895 -0.3784 0.005767 0.2954
Reference price 2 2.030 1.310 1.265 1.470
Nbr of stocks (in thousands) 9,000 9,000 8,537 8,524
Announcement Date 12/4/23 8/5/24 14/4/25 12/4/26
1EUR in Million2EUR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 10.73M
31.77x11.54x23.41x0.62% 994B
29.54x - - 2.02% 640B
32.92x7.63x15.78x2.67% 454B
18.71x4.57x11.31x2.91% 337B
19.41x5.08x12.59x3.23% 261B
20.34x4.19x11.96x2.11% 246B
23.87x6.3x11.23x2.67% 204B
12.3x4.48x9.37x4.08% 190B
-43.47x6.35x24.81x2.29% 178B
Average 16.16x 6.27x 15.06x 2.51% 350.48B
Weighted average by Cap. 23.19x 7.72x 17.10x 2.05%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. ERFO Stock
  4. Valuation Laboratorio Farmaceutico Erfo S.p.A.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!